Cyrusone Inc (CONE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 318,400 | 304,100 | 284,600 | 298,600 | 268,400 |
| Total expenses | 320,200 | 295,600 | 266,000 | 284,600 | 258,000 |
| Operating Income | -1,800 | 8,500 | 18,600 | 14,000 | 10,400 |
| Interest Expense | 17,400 | 17,300 | 14,800 | 15,100 | 14,500 |
| Other Income | 12,200 | 14,500 | 1,300 | 17,700 | 23,800 |
| Pre-tax Income | -7,000 | 5,700 | 5,100 | 16,600 | 19,700 |
| Income Tax | 0 | -1,000 | -2,300 | -1,600 | 700 |
| Net Income Continuous | -7,000 | 6,700 | 7,400 | 18,200 | 19,000 |
| Net Income | $-7,000 | $6,700 | $7,400 | $18,200 | $19,000 |
| EPS Basic Continuous Ops | -0.06 | 0.05 | 0.06 | 0.15 | 0.15 |
| EPS Basic Total Ops | -0.06 | 0.05 | 0.06 | 0.15 | 0.15 |
| EPS Diluted Continuous Ops | -0.06 | 0.05 | 0.06 | 0.15 | 0.15 |
| EPS Diluted Total Ops | -0.06 | 0.05 | 0.06 | 0.15 | 0.15 |
| EPS Diluted Before Non-Recurring Items | 0.02 | 0.05 | 0.01 | 0.15 | 0.15 |
| EBITDA(a) | $126,900 | $138,200 | $144,200 | $137,000 | $130,500 |